2018 annual financial data
Intellia Therapeutics 2018 Operating margin
Intellia Therapeutics 2018 operating margin with verified reported values.
Direct answer
Operating margin was -298.58%.
Operating income was -90,870,000 USD and net income was -85,343,000 USD.
Operating cash flow was -61,257,000 USD.
Get free Intellia Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 30,434,000 USD
- Operating income
- -90,870,000 USD
- Net income
- -85,343,000 USD
- Operating cash flow
- -61,257,000 USD